重症COVID–19肺炎の急性期の循環動態は比較的安定している~単施設・症例対照研究~(Critically ill patients with novel coronavirus infectious disease (COVID–19) are relatively hemodynamically stable in the acute phase: a single–centered, retrospective, observational study)
{"title":"重症COVID–19肺炎の急性期の循環動態は比較的安定している~単施設・症例対照研究~(Critically ill patients with novel coronavirus infectious disease (COVID–19) are relatively hemodynamically stable in the acute phase: a single–centered, retrospective, observational study)","authors":"船登 有未, 松田 航, 植村 樹, 小林 憲太郎, 佐々木 亮, 岡本 竜哉, 木村 昭夫","doi":"10.1002/jja2.12739","DOIUrl":null,"url":null,"abstract":"ABSTRACT To clarify the clinical course of severe COVID–19 pneumonia requiring ventilator support, we investigated the difference of SOFA scores between severe COVID–19 pneumonia and severe pneumonia patients before the emergence of COVID–19. In this single–centered, retrospective, observational study, we enrolled 14 COVID–19 patients requiring ventilator management between February 2020 and May 2020 (COVID–19 group) and 14 patients with pneumonia requiring ventilator management between January 2017 to December 2018 (non–COVID–19 group). We investigated demographic data, laboratory values, treatment, and the SOFA scores on Day 0, 1, and 3, with Day 0 being the day of intubation. The mean age of the 14 COVID–19 patients was 68.3 years and there was no difference in comorbidities and in–hospital mortality with the two groups. The mean SOFA scores (COVID–19 vs. non–COVID–19 group) on the day of intubation were 3.0 vs. 3.1 for respiratory system, 0.1 vs. 2.8 for cardiovascular system, 0.5 vs. 0.6 for coagulation, 0.3 vs. 0.6 for hepatobiliary system, 0.8 vs. 1.6 for central nervous system, and 0.4 vs. 1.3 for renal system, respectively. Significant differences were recognized in cardiovascular system (p<0.01) and central nervous system (p=0.049). The SOFA subscores for cardiovascular system remained significantly lower in the COVID group on Day 1 and 3. The rate of patients who used any vasopressors and the median fluid volume on the day of intubation were significantly lower in COVID–19 group. In conclusion, the hemodynamics were seemed to be more stable in severe COVID–19 pneumonia compared to non–COVID–19 severe pneumonia.","PeriodicalId":200165,"journal":{"name":"Nihon Kyukyu Igakkai Zasshi","volume":"22 2 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nihon Kyukyu Igakkai Zasshi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/jja2.12739","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
ABSTRACT To clarify the clinical course of severe COVID–19 pneumonia requiring ventilator support, we investigated the difference of SOFA scores between severe COVID–19 pneumonia and severe pneumonia patients before the emergence of COVID–19. In this single–centered, retrospective, observational study, we enrolled 14 COVID–19 patients requiring ventilator management between February 2020 and May 2020 (COVID–19 group) and 14 patients with pneumonia requiring ventilator management between January 2017 to December 2018 (non–COVID–19 group). We investigated demographic data, laboratory values, treatment, and the SOFA scores on Day 0, 1, and 3, with Day 0 being the day of intubation. The mean age of the 14 COVID–19 patients was 68.3 years and there was no difference in comorbidities and in–hospital mortality with the two groups. The mean SOFA scores (COVID–19 vs. non–COVID–19 group) on the day of intubation were 3.0 vs. 3.1 for respiratory system, 0.1 vs. 2.8 for cardiovascular system, 0.5 vs. 0.6 for coagulation, 0.3 vs. 0.6 for hepatobiliary system, 0.8 vs. 1.6 for central nervous system, and 0.4 vs. 1.3 for renal system, respectively. Significant differences were recognized in cardiovascular system (p<0.01) and central nervous system (p=0.049). The SOFA subscores for cardiovascular system remained significantly lower in the COVID group on Day 1 and 3. The rate of patients who used any vasopressors and the median fluid volume on the day of intubation were significantly lower in COVID–19 group. In conclusion, the hemodynamics were seemed to be more stable in severe COVID–19 pneumonia compared to non–COVID–19 severe pneumonia.
重症COVID - 19肺炎急性期循环动态相对稳定~单设施病例对照研究~ (Critically ill patients with novel coronavirusinfectious disease (COVID - 19) are relatively hemodynamically stable in the acute phase:a single - centered, retrospective, observational study)
为明确COVID-19重症肺炎需要呼吸机支持的临床病程,我们研究了COVID-19重症肺炎与出现COVID-19前重症肺炎患者SOFA评分的差异。在这项单中心、回顾性、观察性研究中,我们招募了14名2020年2月至2020年5月期间需要呼吸机管理的COVID-19患者(COVID-19组)和14名2017年1月至2018年12月期间需要呼吸机管理的肺炎患者(非COVID-19组)。我们调查了第0、1和3天的人口统计数据、实验室值、治疗和SOFA评分,第0天为插管日。14例新冠肺炎患者的平均年龄为68.3岁,合并症和住院死亡率两组无差异。插管当天(COVID-19组与非COVID-19组)的平均SOFA评分分别为呼吸系统3.0 vs 3.1、心血管系统0.1 vs 2.8、凝血系统0.5 vs 0.6、肝胆系统0.3 vs 0.6、中枢神经系统0.8 vs 1.6、肾脏系统0.4 vs 1.3。心血管系统(p<0.01)和中枢神经系统(p=0.049)差异有统计学意义。在第1天和第3天,COVID组心血管系统的SOFA评分仍显着降低。COVID-19组患者使用任何血管加压药物的比例和插管当日的中位液量均显著降低。综上所述,与非COVID-19重症肺炎相比,重症肺炎患者的血流动力学似乎更稳定。